• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Guiding Appropriate Cancer Treatment with Molecular Residual Disease Testing

home / newsnetwork / guiding-appropriate-cancer-treatment-with-molecular-residual-disease-testing

Jason Starr, DO, discusses the importance of molecular residual disease within the cancer treatment landscape.

© 2023 MJH Life Sciences
All rights reserved.